Learn how integrated development strategies, advanced technology platforms, and a robust CMC framework enable faster progression from DNA to IND and BLA.
Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics CMC activities account for nearly 18% ...
Recognized as Biologics CDMO of the Year, BioDlink shares insights into the world's first approved EGFR-targeted ADC for recurrent/metastatic nasopharyngeal carcinoma The company enables seamless ...
Dr. Olga Paley, Director of Bioprocess Development at Takeda, will discuss “Advancing Takeda’s Bioprocessing Platforms in Support of Clinical and Commercial Drug Supply” about the Chemistry, ...
Toronto, Ontario and Haifa, Israel--(Newsfile Corp. - February 10, 2026) - NurExone Biologic Inc. (NRX:CA) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results